OCS Liver PROTECT Continuation Post-Approval Study
1 other identifier
observational
300
1 country
17
Brief Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2016
CompletedFirst Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2021
CompletedJanuary 9, 2024
December 1, 2023
5.8 years
October 15, 2021
January 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Liver Graft Survival
Liver Graft Survival through 2 years (24 months) after transplantation.
2 years
Other Outcomes (1)
Patient Survival
2 years
Study Arms (2)
OCS Liver
Control
Interventions
Eligibility Criteria
Subjects transplanted in the OCS Liver PROTECT Trial
You may qualify if:
- Subjects transplanted in the OCS Liver PROTECT Trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TransMedicslead
Study Sites (17)
University of California San Diego
La Jolla, California, 92037, United States
Scripps
San Diego, California, 92121, United States
University of California San Francisco
San Francisco, California, 94143, United States
Tampa General
Tampa, Florida, 33606, United States
Emory
Atlanta, Georgia, 30322, United States
Johns Hopkins
Baltimore, Maryland, 21205, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Henry Ford Hospital
Detroit, Michigan, 48202, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Ohio State University Medical Center
Columbus, Ohio, 43210, United States
University of Tennessee Health Science Center
Memphis, Tennessee, 38104, United States
University of Texas Southwest
Dallas, Texas, 75390, United States
Houston Methodist Hospital
Houston, Texas, 77030, United States
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
University of Virginia
Charlottesville, Virginia, 22903, United States
Virginia Commonwealth University Health System
Richmond, Virginia, 23298, United States
University of Washington
Seattle, Washington, 98195, United States
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2021
First Posted
October 27, 2021
Study Start
January 24, 2016
Primary Completion
November 5, 2021
Study Completion
November 5, 2021
Last Updated
January 9, 2024
Record last verified: 2023-12